I

Innate Pharma

219 employees

Innate Pharma is a biopharmaceutical company developing immunotherapy drug candidates for the treatment of cancer and inflammatory diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
biotechnologies
immunotherapy
Medical
antibodies
Pharmaceutical
Biopharma
Clinical Trials
oncology

Date founded

1999

Funding rounds raised

Total raised

$32M

from 18 investors over 18 rounds

I

Innate Pharma raised $32M on January 5, 2022

Investors: Societe Generale

I

Innate Pharma raised $27M on November 20, 2013

Investors: Redmile Group and QVT Financial LLP

I

Innate Pharma raised $18M on September 1, 2004

Investors: Gimv, Novo Nordisk Ltd, Auriga Partners, Sofinnova Partners, Ardian and -

I

Innate Pharma raised $18M on January 1, 2002

Investors: Gimv, Gilde Healthcare, Auriga Partners, Ardian, - and Sofinnova Partners

I

Innate Pharma raised $4.4M on March 20, 2000

Investors: Gimv, Auriga Partners and Sofinnova Partners

FAQ